Background: We examined the relationship between 10-year predicted atherosclerosis cardiovascular disease (AS-CVD) risk score and 25-hydroxyvitamin D in Koreans aged 40-79 years. Methods: A population-based, cross-sectional design was used from data based on the Korea National Health and Nutrition Examination Survey 2014. Results: A total of 1,134 healthy Koreans aged 40-79 years were included. A positive relationship between serum 25-hydroxyvitamin D level and ASCVD score was shown in women (b=0.015) after adjusting for central obesity, physical activity, and supplement intake. The chances of being in the moderate to high risk (risk group, ASCVD score ≥5%) with vitamin D sufficiency (serum 25-hydroxyvitamin D ≥20 ng/mL) was 1.267-fold (95% confidence interval, 1.039-1.595) greater than the chance of being included in the group with vitamin D deficiency (serum 25-hydroxyvitamin D <20 ng/mL) after adjustments in women. Conclusion: Our research indicated a significantly positive association between 25-hydroxyvitamin D and ASCVD score. Further detailed studies to evaluate this correlation are needed.
INTRODUCTION
The American College of Cardiology (ACC) and the American Heart Association (AHA) developed new guidelines for cardiovascular risk assessment in 2013 to quantitatively predict the 10-year risk for first atherosclerotic cardiovascular disease event. The recent guidelines included risks such as age, total cholesterol, high-density lipoprotein (HDL) cholesterol, smoking status, diabetes, and hypertension, which are widely accepted to be major risk factors for cardiovascular disease.
These guidelines can be also used to predict stroke event or peripheral artery diseases, apart from cardiovascular disease. 1) Meanwhile, several studies have reported that lower vitamin D levels are correlated with metabolic syndrome, which is an important risk factor for cardiovascular diseases. There is accumulating epidemiological evidence from observational studies suggesting that cardiovascular diseases are associated with vitamin D deficiency. [2] [3] [4] 
METHODS

Study Population
This study was performed based on data from the 2014 6th Korean National Health and Nutrition Examination Survey (KNHANES). Random sampling and a cross-sectional design was used. Participants who had a diagnosis of congestive heart failure, known coronary heart disease, heart attack, or stroke were excluded from the analysis. We also excluded samples with no vitamin D concentration data or individuals who were bedridden and incapable of any physical activity.
Thus, 1,134 healthy Korean men (N=564) and women (N=570) participated in our examination. All participants who took part in the study provided written informed consent.
Measurements
Systolic blood pressure and diastolic blood pressure were measured on the subjects' right arm with the subject in a sitting position after 10 minutes of rest using an automated sphygmomanometer. Three consecutive readings of systolic and diastolic blood pressure were taken once per minute and the average value was used for the analysis.
Other demographic variables known to affect the results, such as body mass index (BMI), waist circumference, triglyceride, fasting glucose level, oral nutritional supplements, and physical activity were also analyzed in this study. Obesity, central obesity, physical activity, and oral supplementation were considered as confounding factors. 
Atherosclerosis Cardiovascular Disease Risk Score Estimation
The variables in the equation for the 10-year risk assessment for AS-CVD event included age, sex, race, total cholesterol, HDL cholesterol, systolic blood pressure, hypertension, diabetes mellitus, and current smoking status. The 10-year ASCVD event risk score was calculated using the published Pooled Cohort Equation-based algorithm. 1) Participants were divided into two groups according to ASCVD score: lowrisk group (risk score <5%) versus moderate to high-risk group (risk score ≥5%, risk group).
Statistical Analyses
Continuous variables were analyzed using the t-test and categorical 
RESULTS
Finally, 1,134 Koreans (564 men and 570 women) were included after excluding subjects with missing data, known severe cardiovascular disease, and physically inactivity. Participants' characteristics were summarized in Table 1 . The average level of serum vitamin D was 18.42 ng/mL for men and 16.37 ng/mL for women. The average AS-CVD risk score was 9.279% for men and 3.52% for women. More men were included in the high-risk group compared to women. The proportion of regular physical activity was almost evenly distributed in both groups. Oral supplementation was more prevalent in women compared to men. In Table 3 , model 2 displayed a positive association between serum vitamin D level and logarithm-transformed ASCVD score in women after adjusting for central obesity, physical activity, and oral supplements (b=0.015, P=0.022) as confounding variables by linear regression analysis, whereas the association was not statistically significant in men.
We also evaluated the association between serum 25(OH)D and 
DISCUSSION
In this study, central obesity, physical activity, and oral supplements were adjusted, as these factors were considered to relate to serum vita- ed with a number of cardiovascular diseases. 10, 11) However, in the present study, it appears that age as a variable would play an influential factor for our results in women. As shown in our Table 2 The average ASCVD score and the prevalence of being in the highrisk group were higher in men than in women. One possible reason can be due to the different prevalence of cigarette smoking in men and women, as a smoking is thought to exert an influence on predicting the ASCVD scores in our study. The prevalence of tobacco use is 39.3%
and 5.5% in men and women, respectively, from 2015 Korean data showing a lower rate of tobacco use in women. 18) However, the smoking rate among women may be underestimated due to inaccuracies in showing discrepancies in smoking rate between self-reported surveys and urinary nicotine levels. Furthermore, we observed a higher prevalence of smoking in men in our study, which was oriented towards elderly individuals, and it influenced the ASCVD scores in men. In addition, a higher prevalence of diabetes mellitus would be another explanation for higher ASCVD score in men than in women.
The strength of this study is that it is the first nationwide research to assess interactions between serum 25(OH)D concentration and 10-year ASCVD risk score. We explored the relationship after adjusting for obesity, physical activity, and oral nutritional supplements by using a large, representative, population-based sample of data from Korea.
There were also several limitations. First, the cross-sectional design of the study is a major weakness. Causality cannot be drawn from present study and our results cannot guarantee being part of future guidelines for physicians. Therefore, a longitudinal controlled trial is required to confirm these findings. Second, since it is based predomi- In future studies, analyzing exact ingredients such as dietary intake of vitamin D fortified products, oral vitamin D supplements, and cholecalciferol injection status should be conducted to validate our results.
In conclusion, our research indicated women with higher serum 25(OH)D were likely to show higher ASCVD score and also be in a high-risk group based on ASCVD score in Korea. This article was able to assess the relationship between serum 25(OH)D and ASCVD score for the first time.
